Entrada Therapeutics, Inc. (TRDA)
7.015
+0.18
(+2.56%)
USD |
NASDAQ |
May 11, 16:00
6.71
-0.30
(-4.35%)
After-Hours: 18:34
Entrada Therapeutics EPS Diluted (Quarterly) : -0.9493 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.024 |
| Tyra Biosciences, Inc. | -0.5655 |
| Biogen, Inc. | 2.153 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| XOMA Royalty Corp. | 0.2586 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.72M |
| Revenue (Quarterly) | 0.875M |
| Total Expenses (Quarterly) | 40.59M |
| Enterprise Value | 60.42M |
| Gross Profit Margin (Quarterly) | 8.00% |
| Profit Margin (Quarterly) | -4.54K% |
| Earnings Yield | -56.99% |
| Normalized Earnings Yield | -56.53 |